mutations braf gene human cancer 
cancers arise owing accumulation mutations critical genes alter normal programmes cell proliferation differentiation death first stage systematic genome-wide screen genes prioritized analysis signalling pathways least one gene mutated human cancer ras-raf-mek-erk-map kinase pathway mediates cellular responses growth signals1 ras mutated oncogenic formin % human cancer three raf genes code cytoplasmic serine/threonine kinases regulated binding ras1- report braf somatic missense mutations % malignant melanomas lower frequency wide range human cancers mutations within kinase domain single substitution v599e accounting % mutated braf proteins elevated kinase activity transforming nih3t3 cells furthermore ras function required growth cancer cell lines v599e mutation braf serine/threonine kinase commonly activated somatic point mutation human cancer may provide new therapeutic opportunities malignant melanoma 
